NCT02168751View on ClinicalTrials.gov

Inflammatory Response Secondary Using Intravenous Anesthesia Versus Inhalation Anesthesia With Halogenated Agents

PHASE4CompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Pulmonary Resection

Interventions

DRUG

propofol

DRUG

Sevoflurane

Trial Locations (1)

28007

Anesthesiology Department Hospital GU Gregorio Mrañón, Madrid

All Listed Sponsors

collaborator

Ministry of Health, Spain

OTHER_GOV

lead

Hospital General Universitario Gregorio Marañon

OTHER

NCT02168751 - Inflammatory Response Secondary Using Intravenous Anesthesia Versus Inhalation Anesthesia With Halogenated Agents | Biotech Hunter | Biotech Hunter